BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21358106)

  • 1. Good clinical and cost outcomes using dexrazoxane to treat accidental epirubicin extravasation.
    Arroyo PA; Perez RU; Feijoo MA; Hernandez MA
    J Cancer Res Ther; 2010; 6(4):573-4. PubMed ID: 21358106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of dexrazoxane for the prevention of anthracycline extravasation injury.
    Hasinoff BB
    Expert Opin Investig Drugs; 2008 Feb; 17(2):217-23. PubMed ID: 18230055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexrazoxane efficacy for anthracycline extravasation: use in UK clinical practice.
    Muthuramalingam S; Gale J; Bradbury J
    Int J Clin Pract; 2013 Mar; 67(3):244-9. PubMed ID: 23409691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anthracycline extravasation with dexrazoxane -- clinical experience.
    Frost A; Gmehling D; Azemar M; Unger C; Mross K
    Onkologie; 2006 Jul; 29(7):314-8. PubMed ID: 16874015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation.
    Tyson AM; Gay WE
    Ann Pharmacother; 2010 May; 44(5):922-5. PubMed ID: 20371757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexrazoxane for anthracycline extravasation.
    Langer SW
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1081-8. PubMed ID: 18028016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Other uses of dexrazoxane: Savene, the first proven antidote against anthracycline extravasation injuries.
    Langer SW; Jensen PB; Sehested M
    Cardiovasc Toxicol; 2007; 7(2):151-3. PubMed ID: 17652821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxane.
    Langer SW; Thougaard AV; Sehested M; Jensen PB
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):573-6. PubMed ID: 22143379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients.
    Galetta F; Franzoni F; Cervetti G; Cecconi N; Carpi A; Petrini M; Santoro G
    Biomed Pharmacother; 2005 Dec; 59(10):541-4. PubMed ID: 16325366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines.
    Jensen JN; Lock-Andersen J; Langer SW; Mejer J
    Scand J Plast Reconstr Surg Hand Surg; 2003; 37(3):174-5. PubMed ID: 12841619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Totect: a new agent for treating anthracycline extravasation.
    Schulmeister L
    Clin J Oncol Nurs; 2007 Jun; 11(3):387-95. PubMed ID: 17623623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexrazoxane use in the prevention of anthracycline extravasation injury.
    Hasinoff BB
    Future Oncol; 2006 Feb; 2(1):15-20. PubMed ID: 16556068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin.
    Conde-Estévez D; Saumell S; Salar A; Mateu-de Antonio J
    Anticancer Drugs; 2010 Sep; 21(8):790-4. PubMed ID: 20671512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.
    Kane RC; McGuinn WD; Dagher R; Justice R; Pazdur R
    Oncologist; 2008 Apr; 13(4):445-50. PubMed ID: 18448560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide.
    Prescrire Int; 2009 Feb; 18(99):6-8. PubMed ID: 19382398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dexrazoxane in anthracycline induced cardiotoxicity and extravasation].
    Goey AK; Schellens JH; Beijnen JH; Huitema AD
    Ned Tijdschr Geneeskd; 2010; 154():A1155. PubMed ID: 20619024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexrazoxane in anthracycline extravasation.
    Langer SW; Sehested M; Jensen PB; Buter J; Giaccone G
    J Clin Oncol; 2000 Aug; 18(16):3064. PubMed ID: 10944144
    [No Abstract]   [Full Text] [Related]  

  • 18. Dexrazoxane: a management option for anthracycline extravasations.
    Vidall C; Roe H; Dougherty L; Harrold K
    Br J Nurs; 2013 Sep 12-25; 22(17):S6 -12. PubMed ID: 24067273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexrazoxane treatment of doxorubicin extravasation injury in four dogs.
    Venable RO; Saba CF; Endicott MM; Northrup NC
    J Am Vet Med Assoc; 2012 Feb; 240(3):304-7. PubMed ID: 22256846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone.
    Langer SW; Thougaard AV; Sehested M; Jensen PB
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):125-8. PubMed ID: 16001176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.